OneMedNet Corp
About OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $1.4M
- Net income
- -$2.8M
- Total assets
- $2.2M
- Market cap
- $36.8M
- Gross margin
- -37.0%
- Operating margin
- -711.3%
- Net margin
- -206.1%
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $1.4M
- Cost of revenue
- $1.9M
- Gross profit
- -$503.0K
- Operating expenses
- $9.2M
- Operating income
- -$9.7M
- Income tax
- $1.0K
- Net income
- -$2.8M
- EPS (basic)
- $-0.06
- EPS (diluted)
- $-0.06
Balance sheet
- Total assets
- $2.2M
- Current assets
- $2.1M
- Total liabilities
- $5.1M
- Current liabilities
- $4.8M
- Shareholders’ equity
- -$3.0M
Cash flow
- Operating cash flow
- -$7.5M
- Investing cash flow
- $2.3M
- Financing cash flow
- $5.6M
- Net cash flow
- $413.0K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $36.8M
- EPS (diluted)
- $-0.06
- Shares outstanding
- 53.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 8, 2023
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $2.8M in FY2025.
- Revenue grew 33% from FY2023 to FY2025.
- Gross margin of -37.0%, net margin -206.1%.
- Trading 78% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review OneMedNet Corp.
Write a review
News about OneMedNet Corp
News & sentiment via Polygon.io
